VRML - バ―ミリオン (Vermillion Inc.)

VRMLのニュース

   Vermillion : Set to Join Russell 3000 Index | MarketScreener  2020/06/11 07:38:15 MarketScreener
Vermillion Set to Join Russell 3000® Index AUSTIN, Texas - June 9, 2020 - Vermillion, Inc. , a bioanalytical-based women's health company focused on… | June 11, 2020
   The Daily Biotech Pulse: Keytruda Setback For Merck, Denali Pulls The Plug On Neurological Asset  2020/06/10 11:30:59 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 9) Dr.Reddy's Laboratories Ltd (NYSE: RDY ) Imara Inc (NASDAQ: IMRA ) IMMURON LTD/S ADR (NASDAQ: IMRN )( reacted to an award of a $3.7 million in DoD funding for a new candidate that offers protection against travelers' diarrhea) Inari Medical Inc (NASDAQ: NARI ) Keros Therapeutics Inc (NASDAQ: KROS ) Neoleukin Therapeutics Inc (NASDAQ: NLTX ) Sarepta Therapeutics Inc (NASDAQ: SRPT ) United Therapeutics Corporation (NASDAQ: UTHR ) Y-mAbs Therapeutics, Inc (NASDAQ: YMAB ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows June 9) Applied Molecular Transport Inc (NASDAQ: AMTI ) (IPOed Friday) Ayala Pharmaceuticals Inc (NASDAQ: AYLA ) Stocks In Focus Melinta Agrees To Take Tetraphase Private For $39M In Cash And $16M In CVRs With the two-way contest for Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH ) ending after AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) pulled out, Melinta announced a definitive merger agreement to acquire Tetraphase, through a tender offer, for an aggregate of $39 million in cash, plus an additional $16 million in cash potentially payable under contingent value rights to be issued in the proposed acquisition.
   Vermillion : Reports First Quarter 2020 Financial Results | MarketScreener  2020/06/02 13:26:11 MarketScreener
Vermillion Reports First Quarter 2020 Financial Results Conference Call scheduled for today, May 14th at 4:30 p.m. ET AUSTIN, Texas - May… | June 2, 2020
   Vermillion Reports First Quarter 2020 Financial Results  2020/05/14 20:01:00 GlobeNewswire
Conference Call scheduled for today, May 14th at 4:30 p.m. ET
   Vermillion Reports Fourth Quarter 2019 Financial Results | MarketScreener  2020/03/26 20:02:03 MarketScreener
Conference Call scheduled for today, March 26th at 4:30 p.m. ET AUSTIN, Texas, March 26, 2020 -- Vermillion, Inc. , a bio-analytical based women’s health company focused on… | March 26, 2020
   Vermillion : Set to Join Russell 3000 Index | MarketScreener  2020/06/11 07:38:15 MarketScreener
Vermillion Set to Join Russell 3000® Index AUSTIN, Texas - June 9, 2020 - Vermillion, Inc. , a bioanalytical-based women's health company focused on… | June 11, 2020
   The Daily Biotech Pulse: Keytruda Setback For Merck, Denali Pulls The Plug On Neurological Asset  2020/06/10 11:30:59 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 9) Dr.Reddy's Laboratories Ltd (NYSE: RDY ) Imara Inc (NASDAQ: IMRA ) IMMURON LTD/S ADR (NASDAQ: IMRN )( reacted to an award of a $3.7 million in DoD funding for a new candidate that offers protection against travelers' diarrhea) Inari Medical Inc (NASDAQ: NARI ) Keros Therapeutics Inc (NASDAQ: KROS ) Neoleukin Therapeutics Inc (NASDAQ: NLTX ) Sarepta Therapeutics Inc (NASDAQ: SRPT ) United Therapeutics Corporation (NASDAQ: UTHR ) Y-mAbs Therapeutics, Inc (NASDAQ: YMAB ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows June 9) Applied Molecular Transport Inc (NASDAQ: AMTI ) (IPOed Friday) Ayala Pharmaceuticals Inc (NASDAQ: AYLA ) Stocks In Focus Melinta Agrees To Take Tetraphase Private For $39M In Cash And $16M In CVRs With the two-way contest for Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH ) ending after AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) pulled out, Melinta announced a definitive merger agreement to acquire Tetraphase, through a tender offer, for an aggregate of $39 million in cash, plus an additional $16 million in cash potentially payable under contingent value rights to be issued in the proposed acquisition.
   Vermillion : Reports First Quarter 2020 Financial Results | MarketScreener  2020/06/02 13:26:11 MarketScreener
Vermillion Reports First Quarter 2020 Financial Results Conference Call scheduled for today, May 14th at 4:30 p.m. ET AUSTIN, Texas - May… | June 2, 2020
   Vermillion Reports First Quarter 2020 Financial Results  2020/05/14 20:01:00 GlobeNewswire
Conference Call scheduled for today, May 14th at 4:30 p.m. ET
   Vermillion Reports Fourth Quarter 2019 Financial Results | MarketScreener  2020/03/26 20:02:03 MarketScreener
Conference Call scheduled for today, March 26th at 4:30 p.m. ET AUSTIN, Texas, March 26, 2020 -- Vermillion, Inc. , a bio-analytical based women’s health company focused on… | March 26, 2020
   Vermillion : Set to Join Russell 3000 Index | MarketScreener  2020/06/11 07:38:15 MarketScreener
Vermillion Set to Join Russell 3000® Index AUSTIN, Texas - June 9, 2020 - Vermillion, Inc. , a bioanalytical-based women's health company focused on… | June 11, 2020
   The Daily Biotech Pulse: Keytruda Setback For Merck, Denali Pulls The Plug On Neurological Asset  2020/06/10 11:30:59 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 9) Dr.Reddy's Laboratories Ltd (NYSE: RDY ) Imara Inc (NASDAQ: IMRA ) IMMURON LTD/S ADR (NASDAQ: IMRN )( reacted to an award of a $3.7 million in DoD funding for a new candidate that offers protection against travelers' diarrhea) Inari Medical Inc (NASDAQ: NARI ) Keros Therapeutics Inc (NASDAQ: KROS ) Neoleukin Therapeutics Inc (NASDAQ: NLTX ) Sarepta Therapeutics Inc (NASDAQ: SRPT ) United Therapeutics Corporation (NASDAQ: UTHR ) Y-mAbs Therapeutics, Inc (NASDAQ: YMAB ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows June 9) Applied Molecular Transport Inc (NASDAQ: AMTI ) (IPOed Friday) Ayala Pharmaceuticals Inc (NASDAQ: AYLA ) Stocks In Focus Melinta Agrees To Take Tetraphase Private For $39M In Cash And $16M In CVRs With the two-way contest for Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH ) ending after AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) pulled out, Melinta announced a definitive merger agreement to acquire Tetraphase, through a tender offer, for an aggregate of $39 million in cash, plus an additional $16 million in cash potentially payable under contingent value rights to be issued in the proposed acquisition.
   Vermillion : Reports First Quarter 2020 Financial Results | MarketScreener  2020/06/02 13:26:11 MarketScreener
Vermillion Reports First Quarter 2020 Financial Results Conference Call scheduled for today, May 14th at 4:30 p.m. ET AUSTIN, Texas - May… | June 2, 2020
   Vermillion Reports First Quarter 2020 Financial Results  2020/05/14 20:01:00 GlobeNewswire
Conference Call scheduled for today, May 14th at 4:30 p.m. ET
   Vermillion Reports Fourth Quarter 2019 Financial Results | MarketScreener  2020/03/26 20:02:03 MarketScreener
Conference Call scheduled for today, March 26th at 4:30 p.m. ET AUSTIN, Texas, March 26, 2020 -- Vermillion, Inc. , a bio-analytical based women’s health company focused on… | March 26, 2020

calendar